These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32794077)

  • 61. Intraperitoneal administration of the antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in the mouse: bioavailability, pharmacokinetics and toxicity after a single dose.
    Evans SM; Young D; Robertson IG; Paxton JW
    Cancer Chemother Pharmacol; 1992; 31(1):32-6. PubMed ID: 1458557
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Determination of danshensu in rat plasma and tissues by high-performance liquid chromatography.
    Zhang ZC; Xu M; Sun SF; Guo H; Qiao X; Han J; Wang BR; Guo DA
    J Chromatogr Sci; 2008 Feb; 46(2):184-90. PubMed ID: 18366881
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Rapid and equivalent systemic bioavailability of the antidotes HI-6 and dicobalt edetate via the intraosseous and intravenous routes.
    Hill SL; Thomas SH; Flecknell PA; Thomas AA; Morris CM; Henderson D; Dunn M; Blain PG
    Emerg Med J; 2015 Aug; 32(8):626-31. PubMed ID: 25414476
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacokinetics and tissue distribution of hydrazinocurcumin in rats.
    Satyavert ; Gupta S; Choudhury H; Jacob S; Nair AB; Dhanawat M; Munjal K
    Pharmacol Rep; 2021 Dec; 73(6):1734-1743. PubMed ID: 34283375
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Maintaining Supersaturation of Nimodipine by PVP with or without the Presence of Sodium Lauryl Sulfate and Sodium Taurocholate.
    Pui Y; Chen Y; Chen H; Wang S; Liu C; Tonnis W; Chen L; Serno P; Bracht S; Qian F
    Mol Pharm; 2018 Jul; 15(7):2754-2763. PubMed ID: 29782805
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872).
    Hajdu R; Thompson R; Sundelof JG; Pelak BA; Bouffard FA; Dropinski JF; Kropp H
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2339-44. PubMed ID: 9371330
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of different doses of borneol on the pharmacokinetics of vinpocetine in rat plasma and brain after intraocular administration.
    Ma Q; Dai M; Zhang H; Bai L; He N
    Xenobiotica; 2020 May; 50(5):580-587. PubMed ID: 31424307
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacokinetic studies of phellodendrine in rat plasma and tissues after intravenous administration using ultra-high performance liquid chromatography-tandem mass spectrometry.
    Li Y; Liu XG; Wang HY; Dong X; Gao W; Xu XJ; Li P; Yang H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Sep; 1029-1030():95-101. PubMed ID: 27428451
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The pharmacokinetics and oral bioavailability studies of columbianetin in rats after oral and intravenous administration.
    Luo Q; Wang CP; Li J; Ma WF; Bai Y; Ma L; Gao XM; Zhang BL; Chang YX
    J Ethnopharmacol; 2013 Oct; 150(1):175-80. PubMed ID: 23994338
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pharmacokinetics and tissue distribution study of 10-methoxycamptothecin in rats following intragastric administration.
    Zheng J; Ji Y; Shao C; Jing L; Wang Y
    J Pharm Biomed Anal; 2018 Feb; 149():564-571. PubMed ID: 29197298
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacokinetics and tissue disposition of lenalidomide in mice.
    Rozewski DM; Herman SE; Towns WH; Mahoney E; Stefanovski MR; Shin JD; Yang X; Gao Y; Li X; Jarjoura D; Byrd JC; Johnson AJ; Phelps MA
    AAPS J; 2012 Dec; 14(4):872-82. PubMed ID: 22956478
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Formulation of nimodipine nanocrystals for oral administration.
    Li J; Fu Q; Liu X; Li M; Wang Y
    Arch Pharm Res; 2016 Feb; 39(2):202-212. PubMed ID: 26584914
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Grapefruit juice increases oral nimodipine bioavailability.
    Fuhr U; Maier-Brüggemann A; Blume H; Mück W; Unger S; Kuhlmann J; Huschka C; Zaigler M; Rietbrock S; Staib AH
    Int J Clin Pharmacol Ther; 1998 Mar; 36(3):126-32. PubMed ID: 9562227
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pharmacokinetics and tissue distribution of halofuginone (NSC 713205) in CD2F1 mice and Fischer 344 rats.
    Stecklair KP; Hamburger DR; Egorin MJ; Parise RA; Covey JM; Eiseman JL
    Cancer Chemother Pharmacol; 2001 Nov; 48(5):375-82. PubMed ID: 11761455
    [TBL] [Abstract][Full Text] [Related]  

  • 75. One-step self-assembled nanomicelles for improving the oral bioavailability of nimodipine.
    Luo JW; Zhang ZR; Gong T; Fu Y
    Int J Nanomedicine; 2016; 11():1051-65. PubMed ID: 27042060
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pharmacokinetics of ethylene glycol. III. Plasma disposition and metabolic fate after single increasing intravenous, peroral, or percutaneous doses in the male Sprague-Dawley rat.
    Frantz SW; Beskitt JL; Tallant MJ; Zourelias LA; Ballantyne B
    Xenobiotica; 1996 May; 26(5):515-39. PubMed ID: 8736063
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma.
    Xu W; Sun J; Zhang TT; Ma B; Cui SM; Chen DW; He ZG
    Acta Pharmacol Sin; 2006 Dec; 27(12):1642-6. PubMed ID: 17112421
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pharmacokinetics of 11-hydroxyaclacinomycin X (ID-6105), a novel anthracycline, after i.v. bolus multiple administration in rats.
    Yoo BI; Ahan KB; Kang MH; Kwon OS; Hong YS; Lee JJ; Lee HS; Ryu JS; Kim TY; Moon DC; Song S; Chung YB
    Arch Pharm Res; 2005 Apr; 28(4):476-82. PubMed ID: 15918523
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Nimodipine: drug pharmacokinetics and plasma adenosine levels in patients affected by cerebral ischemia.
    Blardi P; Urso R; De Lalla A; Volpi L; Perri TD; Auteri A
    Clin Pharmacol Ther; 2002 Nov; 72(5):556-61. PubMed ID: 12426519
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The anti-diabetic effects and pharmacokinetic profiles of bis(maltolato)oxovanadium in non-diabetic and diabetic rats.
    Zhang SQ; Zhong XY; Chen GH; Lu WL; Zhang Q
    J Pharm Pharmacol; 2008 Jan; 60(1):99-105. PubMed ID: 18088510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.